Oncology Management of Toxicities in Patients Being Treated for Polycythemia Vera patient care perspectives By Ruben A. Mesa, MD, FACP
Oncology Nonadherence to Cytoreductive and/or Antithrombotic Therapy in Patients With Polycythemia Vera patient care perspectives By Katherine Walsh, MD, FACP
Oncology Genomics and Personalized Prognosis in Myeloproliferative Neoplasms clinical topic updates By Rami S. Komrokji, MD
Oncology Progressive Leukocytosis and Thrombotic Risk in Polycythemia Vera clinical topic updates By Katherine Walsh, MD, FACP
Oncology Treating Advanced Prostate Cancer While Reducing the Potential for Adverse Events expert roundtables By Oliver Sartor, MD; Peter R. Carroll, MD, MPH; William K. Oh, MD